GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Myrexis MYRX · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2013

Net income

−$11.6m

FY2013FY2013

Free cash flow

−$13.0m

FY2013FY2013

Shareholders' equity

$1.2m

FY2013FY2013

Income statement

Fiscal years

FY2013
Research and development$465,000
Operating income−$12.0m
Net income−$11.6m
Diluted earnings per share-0.39

Balance sheet

At each fiscal year end

FY2013
Total assets$1.2m
Cash and short-term investments$1.2m
Total liabilities$74,000
Shareholders' equity$1.2m
Shares outstanding30m

Cash flow

Fiscal years

FY2013
Cash from operations−$13.0m
Free cash flow−$13.0m
Dividends paid−$78.6m

Latest quarters

By quarter end

Jun 2013Mar 2013Dec 2012Sept 2012Jun 2012Mar 2012Dec 2011Sept 2011
Gross profit$263,000−$2,000−$23,000−$238,000————
Operating income−$153,000−$3.2m−$4.9m−$3.8m−$4.7m−$10.8m−$7.6m−$8.7m
Net income−$151,000−$3.2m−$4.8m−$3.4m−$4.4m−$10.7m−$7.5m−$8.6m
Diluted earnings per share-0.01-0.11-0.18-0.13-0.16-0.40-0.29-0.33
Cash from operations—−$2.0m−$5.0m−$4.0m−$7.0m−$7.0m−$6.0m−$6.0m
Total assets$1.2m$1.7m$83.5m$87.7m$91.7m$99.0m$106.3m$113.0m
Cash and short-term investments$1.2m$1.5m$81.3m$84.3m$88.4m$68.2m$80.7m$100.6m
Shareholders' equity$1.2m$1.3m$82.2m$86.1m$89.4m$93.4m$103.3m$109.8m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-37.1%-17.5%—
Net income-37.2%-19.5%—

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return-71%79%3740%-94%72%138%277%344%1321%91%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 19 Feb 2013.

FY2013
Paid in the year0.00

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.